Medical Research News

Nursing

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lapperre TS et al. – This randomized trial compared treatment with fluticasone for 6 months, fluticasone for 30 months, fluticasone and salmeterol for 30 months, or placebo in steroid–naive patients who had COPD, most of whom had airway hyperresponsiveness. Investigators found reduced inflammatory cells in sputum and bronchial biopsies and attenuated decrease in lung function during fluticasone treatment. Adding salmeterol did not further alter the decrease in lung function. Steroids not only reduce inflammation but can also slow decrease in lung function in some subphenotypes of steroid–naive patients with COPD.

Today in Clinical Pharmacology...keeping you current

Combination therapy of statins and fibrates in the management of cardiovascular risk
Current Opinion in Lipidology, 12/15/09

Polypill: the evidence and the promise
Current Opinion in Lipidology, 12/15/09

Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/15/09

Today in Pulmonology...keeping you current

Respiratory function in an ageing population
Reviews in Clinical Gerontology, 12/15/09

Soft palate length and upper airway relationship in OSA and non-OSA subjects
Sleep and Breathing, 12/15/09

Ventilation and oxygen: cumulative effects of oxygen on ventilation induced lung injury
Pediatric Research, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address